Literature DB >> 28499703

miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Lizandra Jimenez1, Jihyeon Lim2, Berta Burd3, Thomas M Harris4, Thomas J Ow4, Nicole Kawachi4, Thomas J Belbin4, Ruth Angeletti3, Michael B Prystowsky4, Geoffrey Childs4, Jeffrey E Segall5.   

Abstract

Invasion is a hallmark of advanced head and neck squamous cell carcinoma (HNSCC). We previously determined that low relative miR-375 expression was associated with poor patient prognosis. HNSCC cells with increased miR-375 expression have lower invasive properties and impaired invadopodium activity. Using stable isotope labeling with amino acids in cell culture and reverse-phase liquid chromatography mass spectrometry, we assessed the impact of miR-375 expression on protein levels in UM-SCC-1 cells. Increased miR-375 expression was associated with down-regulation of proteins involved in cellular assembly and organization, death and survival, and movement. Two invasion-associated proteins, vimentin and L-plastin, were strongly down-regulated by miR-375. Luciferase reporter assays demonstrated that high miR-375 expression reduced vimentin promoter activity, suggesting that vimentin is an indirect target of miR-375. Runt-related transcription factor 1 (RUNX1) is a potential miR-375 direct target, and its knockdown reduced vimentin and L-plastin expression. Data in The Cancer Genome Atlas HNSCC database showed a significant inverse correlation between miR-375 expression and RUNX1, vimentin, and L-plastin RNA expression. These clinical correlations validate our in vitro model findings and support a mechanism in which miR-375 suppresses RUNX1 levels, resulting in reduced vimentin and L-plastin expression. Furthermore, knockdown of RUNX1, L-plastin, and vimentin resulted in significant reductions in cell invasion in vitro, indicating the functional significance of miR-375 regulation of specific proteins involved in HNSCC invasion.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28499703      PMCID: PMC5500828          DOI: 10.1016/j.ajpath.2017.02.019

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  61 in total

1.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 2.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

Review 3.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

4.  Regulation of vimentin gene transcription in human breast cancer cell lines.

Authors:  C L Sommers; J M Skerker; S A Chrysogelos; M Bosseler; E P Gelmann
Journal:  Cell Growth Differ       Date:  1994-08

5.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome.

Authors:  Kerry M Bauer; Amanda B Hummon
Journal:  J Proteome Res       Date:  2012-08-27       Impact factor: 4.466

6.  Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.

Authors:  Martin Klemke; Maria T Rafael; Guido H Wabnitz; Tatjana Weschenfelder; Mathias H Konstandin; Natalio Garbi; Frank Autschbach; Wolfgang Hartschuh; Yvonne Samstag
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

Review 7.  MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance.

Authors:  Hsi-Feng Tu; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 2.064

8.  Transactivation of vimentin by beta-catenin in human breast cancer cells.

Authors:  Christine Gilles; Myriam Polette; Mélanie Mestdagt; Béatrice Nawrocki-Raby; Philippe Ruggeri; Philippe Birembaut; Jean-Michel Foidart
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

9.  Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis.

Authors:  Mihoko Sutoh Yoneyama; Shingo Hatakeyama; Tomonori Habuchi; Takamitsu Inoue; Toshiya Nakamura; Tomihisa Funyu; Gerhard Wiche; Chikara Ohyama; Shigeru Tsuboi
Journal:  Eur J Cell Biol       Date:  2014-04-15       Impact factor: 4.492

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  4 in total

1.  Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice.

Authors:  Hanan Aljohani; Joseph P Stains; Sunipa Majumdar; Deepa Srinivasan; Linda Senbanjo; Meenakshi A Chellaiah
Journal:  Bone Res       Date:  2021-04-09       Impact factor: 13.567

2.  Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.

Authors:  Jiahe Wu; Jianlei Cao; Xiaorong Hu; Yongzhen Fan; Chenze Li
Journal:  BMC Med Genomics       Date:  2021-11-29       Impact factor: 3.063

3.  Silencing of circHIPK3 hampers platelet-derived growth factor-induced proliferation and migration in airway smooth muscle cells through the miR-375/MMP-16 axis.

Authors:  Yu Jiang; Xiaoqing Guo; Junhong Qin
Journal:  Cytotechnology       Date:  2021-07-04       Impact factor: 2.040

4.  MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin.

Authors:  Yibo Dong; Yang Zheng; Chundi Wang; Xu Ding; Yifei Du; Laikui Liu; Wei Zhang; Wei Zhang; Yi Zhong; Yunong Wu; Xiaomeng Song
Journal:  Cancer Cell Int       Date:  2018-08-28       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.